Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)

Hagop M. Kantarjian*, Kebede H. Begna, Jessica K. Altman, Stuart L. Goldberg, Mikkael A. Sekeres, Stephen A. Strickland, Martha L. Arellano, David F. Claxton, Maria R. Baer, Marc Gautier, Ellin Berman, Karen Seiter, Scott R. Solomon, Gary J. Schiller, Selina M. Luger, Aleksandra Butrym, Gianluca Gaidano, Xavier G. Thomas, Pau Montesinos, David A. RizzieriDonald P. Quick, Parameswaran Venugopal, Rakesh Gaur, Lori J. Maness, Tapan M. Kadia, Farhad Ravandi, Marc E. Buyse, Judy H. Chiao

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)'. Together they form a unique fingerprint.

INIS

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry